Forbion
Naardenforbion.com
Overview
Forbion is a global venture capital firm that invests in life sciences and bioeconomy companies, managing multiple fund strategies across all stages of drug development.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| RQ Biotechnology Limited | Jun 2026 | Series A | Co-investor |
| Memento Medicines | Jun 2026 | Series A | Lead |
| cAMPfield Therapeutics | Jun 2026 | Series A | Co-investor |
| cAMPfield Therapeutics | May 2026 | Series A | Co-investor |
| CellCentric | May 2026 | Series D | Co-investor |
Key People
Geert-Jan Mulder
Managing Partner
Martien van Osch
Managing Partner
Sander Slootweg
Co-owner and Managing Partner
Alexander Hoffmann
General Partner
Jasper Bos
General Partner
Nanna Lüneborg
General Partner
Carlo Incerti
Operating Partner
Gijs van den Brink
Operating Partner
John Montana
Operating Partner
Rory Gummerson
Operating Partner
Avi Molcho
Venture Partner
Goekben Koca
Venture Partner
Jens Wendland
Venture Partner
Jonathan McNeill
Venture Partner
Josh Brumm
Forbion Venture Partner
Joy Faucher
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
